Skip to content
Riskpilot
← Back to search
Sign in
Get full access
ITH Personalized Cellular Therapies AB
AB
In liquidation
Org 5566970835
Other research and experimental development on natural sciences and engineering
· NACE 7219
Est. 2006
0 employees
Watchlist
Share
Sweden
/
Companies
/
Other research and experimental development on natural sciences and engineering
/
ITH Personalized Cellular Therapies AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
1M
2016
1M
2017
0M
2018
0M
2019
EBITDA
SEK millions
0M
0M
1M
1M
1M
-1M
2016
-1M
2017
-1M
2018
0M
2019
Income statement
SEK thousands
Item
2016
2017
2018
2019
Revenue
1 000
743
249
0
Staff expenses
—
—
—
—
EBITDA
−985
−1 185
−877
472
Depreciation & amort.
−3
−0
−0
−0
EBIT
−988
−1 185
−877
472
Net financials
—
−2
−16
−1
Profit before tax
−988
−1 187
−893
471
Tax
−0
−0
−0
−0
Net profit
−988
−1 187
−893
471
Balance sheet
SEK thousands
Item
2016
2017
2018
2019
Total assets
622
1 516
604
83
Equity
−538
159
−459
72
Long-term debt
0
0
0
0
Short-term debt
1 160
1 357
1 063
11
Total debt
1 160
1 357
1 063
11
Financial ratios
5-year trend
EBITDA margin
47200000.0%
This company
15.8%
Market median
+298734077% vs market
2016
2019
Equity ratio
86.7%
This company
38.2%
Market median
+127% vs market
2016
2019
Return on equity
654.2%
This company
18.4%
Market median
+3455% vs market
2016
2019
Net profit margin
47100000.0%
This company
8.1%
Market median
+581481381% vs market
2016
2019
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2016
2019
Debt / equity
0.15×
This company
0.62×
Market median
+76% vs market
2016
2019
Annual reports & filings
Annual report 2019
Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
View
PDF
Annual report 2018
Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
View
PDF
Annual report 2017
Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
View
PDF
Annual report 2016
Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
View
PDF
More on ITH Personalized Cellular Therapies AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
